Enteral Feeding Devices Market

Enteral Feeding Devices Market Size (2022 to 2027)

The global enteral feeding devices market size is forecasted to be USD 2.4 billion in 2022 and USD 3.06 billion by 2027, growing at a CAGR of 4.97% between 2022 to 2027.

A few of the key insights from this report:

• Based on product type, the enteral feeding pump segment dominated, accounting for 36.8% of the global market in 2021.
• North America dominated the enteral feeding devices market and accounted for 34.2% of the global market share in 2021.
• The market in Europe was valued at USD 690 million in 2021.
• The Asia-Pacific region is anticipated to grow at a CAGR of 6.87% from 2022 to 2027.
• The Latin America region is expected to value USD 250 million by 2027.

Enteral feeding devices are essential for people suffering from medical ailments such as swallowing disorders, digestive disorders, neurological disorders, cancer, etc. With the rise in the population's average age globally, there would be more older people than youth, resulting in increased use of these devices. Existing enteral feeding device manufacturers are starting to adopt innovative technology and methods for patient safety. Using unique connection systems to dodge the misconnection of feeding tubes is one method that decreases the difficulties associated with enteral feeding devices.

MARKET DRIVERS:

Y-O-Y growth in the number of preterm births, increasing prevalence of chronic diseases, a rise in the geriatric population, and technological advancements in the healthcare industry are driving the global enteral feeding devices market.

The World Health Organization (WHO) stated that the number of preterm births is significantly growing, and around 15 million preterm births occur annually. Furthermore, the complications associated with preterm births are among the leading causes of death in children under five years. Therefore, the factor mentioned above is expected to boost the growth of the global enteral feeding devices market.

The high acceptance of enteral nutrition drives the enteral feeding devices market expansion.

The market is being supported by the recent shift of preference from parenteral nutrition methods towards enteral ones, which are less intrusive and produce more consistent results. In addition, the adoption of enteral care into ambulatory services and the recent research and development in this equipment are fuelling the market to grow further. Furthermore, the rising efforts towards healthcare development, especially in economically growing countries, are expected to support the market's growth dynamics. 

The growing prevalence of chronic diseases is favoring the enteral feeding devices market.

As mentioned by the Centers for Disease Control and Prevention, in the United States, 6 in 10 adults suffer from at least 1, and 4 in 10 adults have two or more chronic diseases. Furthermore, the growing need for enteral nutrition, rising malnutrition cases, and the growing geriatric population are other significant factors that further fuel market growth. In addition, technological advancements in enteral feeding devices that comprise consistent changes among the products to suit the single patient requirements also favor the market. 

MARKET RESTRAINTS:

However, the main factors hindering the market's growth are the lack of public awareness, difficulties associated with using these devices, and reimbursement issues in developing countries. Enteral feeding devices' reimbursement policies are insufficient in countries such as APAC, Latin America, and the Middle East & Africa. These insufficient reimbursement policies pose a significant challenge to the extensive adoption of enteral feeding in these countries.

Impact of COVID-19 on the global enteral feeding devices market:

Early March 2020 saw the start of the epidemic, which lasted for over a year. The coronavirus outbreak, which originated in China and spread worldwide, resulted in lockdowns and quarantines. Shipments and travel were restricted, resulting in losses for many enterprises. As additional deaths were reported, the unemployment rate increased, and the economic situation worsened. Due to the sudden surge of patients and the acute lack of hospital supplies, including oxygen cylinders, hospital beds, and staff, the healthcare industry was severely disrupted.

The recent outbreak of the COVID-19 pandemic has changed the dynamics of the enteral feeding devices market and has created an acceleration in the market.

Millions of people worldwide have been diagnosed with COVID-19, which has increased the need for various medical devices, including imaging devices, dental equipment, and other medical supplies. Therefore, it is further prominently impacting the enteral feeding devices market worldwide. Furthermore, the crisis has significantly increased the number of enteral feeding devices for those in intensive care units (ICUs) and those who cannot take food independently. Therefore, with the COVID-19 boost, the global enteral feeding devices market is expected to see new growth heights during the forecast period.

REPORT COVERAGE:

This market research report on the global enteral feeding devices market has been segmented and sub-segmented into the following categories.

Enteral Feeding Devices Market – By Product Type:

• Enteral Feeding Tubes
  • Nasoenteric Feeding Tubes
  • Oroenteric Feeding Tubes
  • Enterostomy Tubes
• Giving Sets
• Enteral Feeding Pumps
• Administration Reservoirs
• Enteral Syringes
• Others

Based on product type, the enteral feeding pumps segment led the market in 2021, with more than half the share going to such products. It is also anticipated to be the fastest-growing among the major five during the forecast period. The segment's dominance is mainly because it is a convenient slow feeding method wherein the patient is slowly administered continuous and direct nutrition, and it is a system that can be performed at home with the help of nurses and caregivers. The system also reduces the number of errors with the feeding system and is a consistent and accurate procedure for the patient's health, making it more favorable. Therefore, the enteral feeding tube segment is considered a lucrative segment and is predicted to register a healthy rate during the forecast period due to the growing adoption of these devices.

However, the enteral feeding pumps segment is also expected to show significant growth during the forecast period due to the increasing preference towards pumps for regular patients. Moreover, in the cases of patients who do not need a continuous nutrition supply ad can digest a good amount of nutrition at once, pumps are the best equipment, thus promoting the segment's expansion in recent times. 

Enteral Feeding Devices Market – By Stage:

• Adults
• Pediatrics

Based on the stage, the pediatrics segment is forecasted to lead the market during the forecast period due to growing occurrences of preterm births worldwide. In addition, the rising cases of the need for personalized healthcare for child patients with growing diagnoses of chronic illness in the underage patient group are expected to support the expansion of this segment. According to the CDC statistics in the United States, 1 in 15 children and around 27% of children have MCCs. Therefore, the high rates of treatment requirement in children, especially for enteric diseases, is leading the segment growth. 

However, the adult segment is also expected to show fast growth during the forecast period due to the rising cases of chronic diseases in adults and the growing geriatric population who need enteric feeding device services. 

Enteral Feeding Devices Market – By Application:

• Gastroenterology
• Neurological Disorders
• Oncology
• Diabetes
• Hyper Metabolism

The oncology segment previously held the largest enteral feeding devices market share based on the application. It is projected to showcase a solid CAGR during the forecast period. Cancer patients tend to use enteral feeding into a vein or stomach. The enteral devices are combined among the patients before their radiotherapy or chemotherapy treatment starts. Proper nutrition acts as an essential role in the treatment of cancer treatments. The food is proficient with enteral feeding devices in patients who cannot absorb the nutrients. Therefore, the high adoption of enteral feeding devices is used to supply clinical nutrients to patients. 

The diabetes segment is estimated to witness a robust CAGR during the forecast period due to the rising of patients with diabetes needing the enteral feeding system. The bulk of the approximately 422 million individuals with diabetes globally reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually. Diabetes is a condition where blood sugar levels need to be steadily maintained, and food intake needs to be watched. This monitoring is supported by the enteral feeding system, further promoting the segment's growth. 

Enteral Feeding Devices Market – By End User:

• Ambulatory Care Services
• Hospitals
• Others

Based on end-user, many hospitals implementing enteral nutrition as an efficient clinical nutrition system are enhancing the market's growth. Due to the increasing number of hospitals worldwide, the hospital sector is anticipated to dominate the market. Hospitals strive to offer the most satisfactory services possible and have sophisticated infrastructure and extensive connections. Additionally, hospitals experience a considerable increase in patients due to the confidence they gain by having skilled staff and reliable medical facilities. Hospitals, therefore, have the most comprehensive availability of medications and equipment, contributing to the segment's supremacy.

The ambulatory care services segment is also expected to show fast growth due to the recent advancements in the services and the increasing preference towards the same. 

Enteral Feeding Devices Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

The North American enteral feeding devices market is projected to dominate the global market, with the highest share during the forecast period. Highly advanced healthcare systems and adopting advanced, patient-friendly enteral feeding devices integrated with safety attributes are the main factors responsible for the large shares of North America and Europe in the global Enteral Feeding Devices market. The United States market is expected to account for most of the share in the North American market due to the increasing per capita income, growing incidence of cancer, and rising number of premature births. As per the U.S. Center for Disease Control and Prevention, there is ongoing diabetic population growth, with 12% of the grown-up population scheduled to have the disease. The Canadian market is to exhibit prominent growth. Older adults face difficulties in consuming food and medications. Enteral feeding devices help them with mounting market demand. 

The European enteral feeding devices market accounted for a significant share of the global market in 2019, with a regular increase in infections and chronic ailments. Around 30% of the patients in Europe are malnourished. Primitive approvals of feeding devices and the high adoption of feeding pumps in the region escalate the market demand. 

However, the Asia-Pacific enteral feeding devices market is projected to grow the highest, owing to the overall development of the healthcare industry. In addition, increasing healthcare expenses and burgeoning consciousness towards safe feeding products supplement the enteral feeding devices market growth during the forecast period. In APAC, the Japanese market is forecasted to account leading share during the forecast period due to the growing nutritional problems in the aging population, increasing the number of hospitals, and healthcare infrastructure.

The Latin American enteral feeding devices market is another lucrative regional market predicted to grow at a promising CAGR between 2020 to 2025. The regional market is strongly driven by the growing number of hospitals and ambulatory care services executing enteral supplements as clinical nutrition. Brazil is expected to be the leading Latin American market, followed by Mexico, Argentina, and Chile. 

The Middle East & African enteral feeding devices market accounted for a smaller global market share in 2021. However, during the forecast period, the MEA enteral feeding devices market is forecasted to grow steadily.

KEY MARKET PARTICIPANTS:

Companies profiled in this report that play a vital role in the global enteral feeding devices market are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.

RECENT HAPPENINGS IN THIS MARKET:

• In May 2022, Avanos Medical faced a Class I recall for a feeding tube system connected to 23 fatalities since 2015. In addition, the FDA has given Avanos Medical's enteral feeding tube insertion equipment its highest severe classification for a recall after seven years of misfortune. A display monitor, an external receiver, and an electromagnetic style are all parts of the Cortrak 2 Enteral Access System. When used in tandem, the device provides a live stream of the insertion of a feeding tube into a patient's stomach or small intestine to enhance tip placement accuracy and minimize problems.
• In April 2022, the highest 2022 FPA Award goes to the prefilled enteral pouch. A 510(k) FDA-approved enteral device for tube-fed patients, the EnteraLoc. It is a flexible spouted pouch with a leak-proof closure for simple and safe direct-connect nutrition administration.
• In October 2021, the FDA-approved low-profile Percutaneous Endoscopic Gastrostomy (PEG) device from Fidmi Medical Ltd. was made available in the United States following the completion of a $2.2 million fundraising round. Leading medical technology businesses Micro-Tech (Nanjing) Co., Ltd., The Trendlines Group, and Agriline are among the investors in the round. Fidmi's only distributor in the United States and China is Micro-Tech.
• In September 2019, CoapTech and Fidmi Medical announced their collaboration. The collaboration was made in integrating the technologies of both companies and developing a new generation of g-tube systems that provide patients with long-term nutritional assistance and are typically implanted endoscopically and changed out every 3-6 months. Unfortunately, tube replacements, hospitalizations, poor nourishment and medicine administration, and complications, including clogging and dislodgement, are all frequent and come at a high cost to individuals and the healthcare system.